论文信息 - Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study - 字舞流文

Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study

J. Baselga | M. Climent | J. Mayordomo | A. Lluch | P. Gascón | S. Di Cosimo | J. Cortés | M. Benavides | H. Cortés-Funes | J. Trigo | L. Cirera | B. Ojeda | J. Vázquez | M. Gil | J. F. Dorado | C. Rodríguez | P. Regueiro